Evidence map›Paper›PMID 33398542›Full record

ArticleInflammation2021

Steroid Receptor Coactivator-3 Is Required for Inhibition of the Intestinal Muscularis Inflammatory Response of Postoperative Ileus in Mice.

Kang Zou, Wenbo Chen, Jun Dai, Pingli Mo, Chundong Yu, Jianming Xu, Sangang Wu, Rengong Zhuo, Guoqiang Su

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Regulatory Role of IGF2BP2 in Intestinal Mucosal Barrier Dysfunction in Ulcerative Colitis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Kang Zou *Department of Gastrointestinal Surgery, Ward 3 Areas of Cancer Center, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China.
Wenbo Chen *Department of Cardiology, The First Affiliated Hospital of Xiamen University, Xiamen, 361003, China.
Jun DaiDepartment of Gastrointestinal Surgery, Ward 3 Areas of Cancer Center, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China.
Pingli MoKey Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen, 361005, China.
Chundong YuKey Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen, 361005, China.
Jianming XuDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
Sangang WuDepartment of Radiation Oncology, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Teaching Hospital of Fujian Medical University, Xiamen, 361003, China.
Rengong ZhuoSchool of Medicine, Xiamen University, Xiang'an District, Xiamen, 361102, China. zhuorg@126.com.ORCID http://orcid.org/0000-0002-2388-2355
Guoqiang SuDepartment of Gastrointestinal Surgery, Ward 3 Areas of Cancer Center, Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen, 361003, China. suguoqiang66@163.com.
Xiamen University · CNFujian Medical University · CNBaylor College of Medicine · USFirst Affiliated Hospital of Xiamen University · CN

Funding

National Natural Science Foundation of China 81601227National Natural Science Foundation of China 81970462Natural Science Foundation of Fujian Province 2015J01548Natural Science Foundation of Fujian Province 2016J05203the Science and Technology Planning Projects of Xiamen Health and Family Planning Commission 3502Z20149004the Science and Technology Planning Projects of Xiamen Science & Technology Bureau 3502Z20154008
6 · The paper itself

Abstract

Inflammation theory has suggested that the pathogenesis of postoperative ileus (POI) involves the steroid receptor coactivator-3 (SRC-3). Therefore, we investigated the role of SRC-3 in the muscles of the small intestine using a mouse POI model. Here, we reported that intestinal manipulation (IM) significantly reduced the extent of phenol red migration in the entire gastrointestinal tract, and the calculated geometric center (GC) value in wild-type (WT) mice at 24 h after surgery was higher than that in the knockout (KO) mice and in the sham-operated control group. The expression of SRC-3 was upregulated in the mouse intestinal muscularis at 24 h after surgical manipulation, and the mRNA and protein levels of inflammatory cytokines were upregulated compared with those in the control group. At 24 h after IM, the number of neutrophils in the experimental group was significantly higher than that in the control group; in the IM group, the number of neutrophils in the SRC-3

Indexed as

Gastrointestinal MotilityAnimalsCytokinesDisease Models, AnimalFemaleIleusInflammation MediatorsIntestine, SmallJejunumMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMuscle, SmoothNeutrophil InfiltrationNuclear Receptor Coactivator 3CytokinesInflammation MediatorsNcoa3 protein, mouseNuclear Receptor Coactivator 3Peroxidaseinflammatory mechanismsintestinal manipulationknockout micepostoperative ileussteroid receptor coactivator-3

Identifiers

PMID33398542
OpenAlexW3120078490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.